A U.S. medical professor facing fraud charges for submitting false data in Alzheimer's disease research, impacting a publicly-listed pharmaceutical company and raising integrity concerns about its drug development. The case highlights the potential consequences of research misconduct.
Study compares ketamine and electroconvulsive therapy for treatment-resistant depression, analyzing patient outcomes based on baseline characteristics and treatment settings.
A longitudinal cohort study reveals that chronic loneliness is associated with a 56% higher risk of incident stroke in middle-aged and older U.S. adults, independent of social isolation and depressive symptoms.
The FDA has expanded the approval of Sarepta Therapeutics' gene therapy, Elevidys, for Duchenne muscular dystrophy in patients aged four and older, addressing both ambulatory and non-ambulatory cases.